BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37637767)

  • 21. RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.
    Snauwaert S; Vanhee S; Goetgeluk G; Verstichel G; Van Caeneghem Y; Velghe I; Philippé J; Berneman ZN; Plum J; Taghon T; Leclercq G; Thielemans K; Kerre T; Vandekerckhove B
    Haematologica; 2012 Oct; 97(10):1539-47. PubMed ID: 22532518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE; Ahlers J; Schäfer I; André M; Kerst G; Scheel-Walter HG; Schwarze CP; Pfeiffer M; Lang P; Handgretinger R; Ebinger M
    Pediatr Hematol Oncol; 2011 Mar; 28(2):91-9. PubMed ID: 21214408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia.
    Martínez A; San Miguel JF; Vidriales MB; Ciudad J; Caballero MD; López-Berges MC; Moro MJ; Calmuntia MJ; Ortega F; Orfao A
    Cytometry; 1999 Apr; 38(2):70-5. PubMed ID: 10323219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
    Bendall LJ; Bradstock KF; Gottlieb DJ
    Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitro.
    Braun S; Gerhartz HH; Schmetzer HM
    Ann Hematol; 2000 Jul; 79(7):363-73. PubMed ID: 10965784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of c-MPL in leukemic stem cells from acute myeloid leukemia patients].
    Yu P; Qiu SW; Rao Q; Lin D; Xing HY; Tang KJ; Tian Z; Wang M; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1052-5. PubMed ID: 23114117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
    Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression of miR-204 is associated with expression of CD34 and poor performance status in denovo AML.
    Abdelhafiz AS; Elsayed GM; Saber MM; Gameel A; Hamdy N
    Int J Lab Hematol; 2020 Jun; 42(3):263-269. PubMed ID: 32048789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of c-kit receptor (CD117) and CD34 in leukemic cells.
    Muroi K; Nakamura M; Amemiya Y; Suda T; Miura Y
    Leuk Lymphoma; 1995 Jan; 16(3-4):297-305. PubMed ID: 7536510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells.
    Jäger P; Geyh S; Twarock S; Cadeddu RP; Rabes P; Koch A; Maus U; Hesper T; Zilkens C; Rautenberg C; Bormann F; Köhrer K; Petzsch P; Wieczorek D; Betz B; Surowy H; Hildebrandt B; Germing U; Kobbe G; Haas R; Schroeder T
    Stem Cells; 2021 Sep; 39(9):1270-1284. PubMed ID: 34013984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
    Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation between Expression of CD47 Molecule in Patients with Newly Diagnosed Adult Acute Myeloid Leukemia and Clinical Prognosis].
    Pan J; Zhang YY; Jiao XX; Song LN; Lin CQ; Wang SL; Zhu B; Pan SY; Ding ZY; Zhao WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1071-1078. PubMed ID: 35981364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
    Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
    Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
    Ho MM; Hogge DE; Ling V
    Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AC133 antigen as a prognostic factor in acute leukemia.
    Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
    Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and Clinical Significance of N-cadherin in Bone Marrow Leukemic Cells Derived from Patients with Acute Leukemia].
    Ma J; Liu YJ; Zhang QT; Yu QF; Zhang ZF; Zhang MY; Wang C; Gan SL; Chen SM; Cao WJ; Xie XS; Yan-Fang L; Liu LX; Wan DM; Wang F; Sun L; Sun H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1312-1318. PubMed ID: 27784348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.